Omers Administration Corp Collegium Pharmaceutical, Inc Transaction History

Omers Administration Corp

  • $10.4 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$31.36 - $39.99 $247,744 - $315,921
7,900 New
7,900 $254,000
Q2 2019

Aug 08, 2019
SELL
$10.62 - $16.59 $166,734 - $260,463
-15,700 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$13.58 - $18.72 $213,206 - $293,904
15,700 New
15,700 $246,000
Q2 2018

Aug 09, 2018
SELL
$21.79 - $28.29 $483,738 - $628,038
-22,200 Closed
0 $0
Q1 2018

May 11, 2018
BUY
$18.15 - $29.21 $402,929 - $648,462
22,200 New
22,200 $567,000

Others Institutions Holding COLL

# of Institutions
254
Shares Held
36.9M
Call Options Held
100K
Put Options Held
21.1K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.12B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Omers Administration Corp Portfolio

Follow Omers Administration Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omers Administration Corp, based on Form 13F filings with the SEC.

News

Stay updated on Omers Administration Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email